Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Liu

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
The Journal of Infection|November 1, 1986
Systemic infection with Aureobasidium pullulans in a leukaemic patientE B Kaczmarski, J A Liu Yin, J A Tooth, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 7, 2015
Parity and osteoporotic fracture risk in postmenopausal women: a dose-response meta-analysis of prospective studiesQ Wang, Q Huang, Y Zeng, et al.
British Journal of Haematology|May 3, 2000
Megakaryopoiesis in vitro in myelodysplastic syndromes and acute myeloid leukaemia: effect of pegylated recombinant human megakaryocyte growth and development factor in combination with other growth factorsJ A Liu Yin, J A Adams, M L Brereton, et al.
Journal of Clinical Pathology|September 5, 2001
Dual colour FISH in paraffin wax embedded bone trephines for identification of numerical and structural chromosomal abnormalities in acute myeloid leukaemia and myelodysplasiaC L Le Maitre, R J Byers, J A Liu Yin, et al.
Biochemical Pharmacology|September 27, 1991
Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activitiesR J Linhardt, A al-Hakim, J A Liu, et al.
British Journal of Haematology|November 1, 1991
Mitozantrone and cytosine arabinoside as first-line therapy in elderly patients with acute myeloid leukaemiaJ A Liu Yin, P R Johnson, J M Davies, et al.
Blood|January 29, 2000
Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapseK Tobal, J Newton, M Macheta, et al.
Blood|January 7, 1998
A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study GroupG Heil, D Hoelzer, M A Sanz, et al.
Annals of Hematology|October 8, 2003
Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia--a randomized, placebo-controlled, double-blind safety and efficacy studyK Geissler, J A Liu Yin, A Ganser, et al.
Leukemia|March 1, 1997
Detection and quantitation of the CBFbeta/MYH11 transcripts associated with the inv(16) in presentation and follow-up samples from patients with AMLP A Evans, M A Short, A S Jack, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The Journal of Infection|November 1, 1986
Systemic infection with Aureobasidium pullulans in a leukaemic patientE B Kaczmarski, J A Liu Yin, J A Tooth, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 7, 2015
Parity and osteoporotic fracture risk in postmenopausal women: a dose-response meta-analysis of prospective studiesQ Wang, Q Huang, Y Zeng, et al.
British Journal of Haematology|May 3, 2000
Megakaryopoiesis in vitro in myelodysplastic syndromes and acute myeloid leukaemia: effect of pegylated recombinant human megakaryocyte growth and development factor in combination with other growth factorsJ A Liu Yin, J A Adams, M L Brereton, et al.
Journal of Clinical Pathology|September 5, 2001
Dual colour FISH in paraffin wax embedded bone trephines for identification of numerical and structural chromosomal abnormalities in acute myeloid leukaemia and myelodysplasiaC L Le Maitre, R J Byers, J A Liu Yin, et al.
Biochemical Pharmacology|September 27, 1991
Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activitiesR J Linhardt, A al-Hakim, J A Liu, et al.
British Journal of Haematology|November 1, 1991
Mitozantrone and cytosine arabinoside as first-line therapy in elderly patients with acute myeloid leukaemiaJ A Liu Yin, P R Johnson, J M Davies, et al.
Blood|January 29, 2000
Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapseK Tobal, J Newton, M Macheta, et al.
Blood|January 7, 1998
A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study GroupG Heil, D Hoelzer, M A Sanz, et al.
Annals of Hematology|October 8, 2003
Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia--a randomized, placebo-controlled, double-blind safety and efficacy studyK Geissler, J A Liu Yin, A Ganser, et al.
Leukemia|March 1, 1997
Detection and quantitation of the CBFbeta/MYH11 transcripts associated with the inv(16) in presentation and follow-up samples from patients with AMLP A Evans, M A Short, A S Jack, et al.
Pageof 4